GlassScriptPhysician profile
Denise Jacks
NPI 1104136738
$3,313.89
in general payments reported to CMS, 2019-2025
22 companies · $831 in 2025
The $831 reported for 2025 was more than what 81% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $711 · 2023: $761 · 2024: $1,011 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,603.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $361.93 | 2023-2024 | Freestyle Libre 3, Cardiomems, Freestyle Libre 2 |
| Astrazeneca Pharmaceuticals LP | $305.06 | 2023-2024 | Breztri, Lokelma, Farxiga |
| Alexion Pharmaceuticals, INC. | $266.92 | 2025 | Strensiq |
| Biohaven Pharmaceutical Holding Company LTD. | $243.37 | 2022 | |
| Novo Nordisk INC | $227.20 | 2022-2024 | Wegovy |
| Boston Scientific Corporation | $213.42 | 2023-2025 | Watchman Access System, Enroute Transcarotid Neuroprotection System |
| Actelion Pharmaceuticals US, INC. | $207.29 | 2023-2024 | Opsumit, Uptravi |
| Edwards Lifesciences Corporation | $138.72 | 2025 | Sapien 3 Ultra Resilia |
| Lilly USA, LLC | $132.08 | 2022-2023 | Jardiance |
| Abbvie INC. | $125.00 | 2022 | |
| Axonics, INC. | $118.06 | 2024 | Axonics, Bulkamid |
| Glaxosmithkline, LLC. | $112.15 | 2023 | |
| Abiomed | $111.56 | 2024 | Impella |
| Amgen INC. | $105.20 | 2022 | |
| Gilead Sciences, INC. | $102.65 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $101.20 | 2025 | |
| Lucid Diagnostics INC. | $100.43 | 2023 | |
| Solventum Corporation | $100.00 | 2025 | V.A.C. Veraflo, V.A.C.Ulta |
| Corcept Therapeutics | $89.71 | 2024 | Korlym |
| Ceribell, INC. | $75.25 | 2025 | Pocket Eeg Device |
| Philips North America LLC | $57.63 | 2025 | Home Pi Undivided |
| Dexcom, INC. | $19.06 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Jacks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.